Cambridge Healthtech Institute's 27th International

Biodetection Technologies

Point-of-Care for Biodefense

June 18-19, 2019

 

The development of bioanalytical devices that are portable, compatible, scalable and reliable is critical to effective biodefense at the point-of-care. In addition, clinical data must be generated and incorporated into the key operational decision-maker networks. Cambridge Healthtech’s 27th International Biodetection Technologies: Point-of-Care for Biodefense will bring together the global industry, academic and government biodefense community to discuss advancements in approaches for optimizing performance of field technologies, translational challenges, regulatory approval of diagnostic tools, and data analysis to enable effective decision-making.

This event is in conjunction with our 27th International Biodetection Technologies: Biothreat and Pathogen Detection, as well as our 8th Annual Biosurveillance Integration conferences. Together, these events will provide three full days of programming around biodetection technologies and biosurveillance in both the field and the lab.

Preliminary Agenda

Optimizing Performance of Traditional Point-Of-Care Detection

Facilitating the Path to Commercialization via Resources Provided by Centers for Point-of-Care Technology

Joany Jackman, PhD, Senior Scientist, Johns Hopkins University Applied Physics Laboratory

Universal Point-of-Care Diagnostics for All Bacterial Pathogens

Harshini Mukundan, PhD, Team Leader, Chemistry Division, Los Alamos National Laboratory

Botulinum Neurotoxin Detection Methods for Public Health Response and Surveillance

Patrick Mcnutt, PhD, Principal Investigator, US Army Medical Research Institute of Chemical Defense, USAMRICD

How to Support Biodefense Policies with Solid Evidence-Based Fact: Lessons Learned from EU Policies that Required Solid Evidence-Based Facts

Guy Van Den Eede, Head of Unit, Knowledge for Health and Consumer Safety, Joint Research Centre (JRC), European Commission

Tools, Technology and Therapeutics at the Point-of-Care

A Smart Phone Platform for Detection of Zika Virus RNA in Low Resource Settings

Robert Meagher, PhD, Staff Scientist, Sandia National Laboratory

An Affordable System for a Rapid Mass Casualty Response to a Large Area Coverage Biological Incident

Steven Hatfill, PhD, Adjunct Assistant Professor, Division of Clinical Research and Leadership, George Washington University School of Medicine

Mass Applicable Vaccines against Highly Pathogenic Influenza Viruses

Juergen Richt, PhD, Regents Distinguished Professor & KBA Eminent Scholar; Director, Department of Homeland Security Center of Excellence for Emerging and Zoonotic Animal Diseases, Kansas State University

Advances in Fieldable Technologies and Assays

Smart Chemical-Morphological NMR Relaxometry Facile Sensor for Food Security and Quality

Zeev Wiesman, PhD, Professor, Biotechnology Engineering, Ben Gurion University

Development of Novel Biomaterials and Bioanalytical Platforms for Biodefense Applications

Jason Harper, PhD, Senior Member of the Technical Staff, Bioenergy and Defense Technologies Department, Sandia National Laboratory




For more details on the conference, please contact:
Craig Wohlers

Executive Director, Conferences

Cambridge Healthtech Institute

Phone: (+1) 781-972-6260
Email: cwohlers@healthtech.com

 

For partnering and sponsorship information, please contact:
Jon Stroup

Senior Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-972-5483
Email: jstroup@healthtech.com